Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Abciximab in Emergent Stroke Treatment Trial - II

Trial Profile

Abciximab in Emergent Stroke Treatment Trial - II

Phase of Trial: Phase III

Latest Information Update: 01 Dec 2008

At a glance

  • Drugs Abciximab (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms AbESTT-II
  • Most Recent Events

    • 01 Dec 2008 Results published in Stroke.
    • 01 Jan 2008 Results have been published.
    • 21 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top